Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech [View all]
https://www.businessinsider.com/curevac-vaccine-efficacy-late-stage-trial-covid-bill-gates-2021-4CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech
Andrew Dunn 12 minutes ago
A COVID-19 vaccine candidate developed by the German biotech CureVac failed in a critical late-stage study, the company said Wednesday.
It's the first failure of a major vaccine candidate in a final-stage trial. CureVac said an interim analysis showed the shot was 47% effective, falling short of the company's target and health officials' standards for coronavirus vaccines. European officials had already secured more than 225 million doses of the shot.
The trial is still ongoing and the final vaccine efficacy figure may vary as more COVID-19 cases are tallied. The interim analysis is based on 134 illnesses. In a statement, CureVac leaders said that virus variants played a role in the result.
(snip)
4 replies
= new reply since forum marked as read
= new reply since forum marked as read